You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤

Peter Radovich

Senior Vice President-Operations at Global Blood Therapeutics, Inc.
Overview
Relationships
In The News
Paths
Education
Career History
Public Holdings

Peter Radovich

Senior Vice President-Operations at Global Blood Therapeutics, Inc.

Overview

Age
40 (Born 1978)
Number of Relationships
This person is connected to 142 people.

Relationships See Details


Partner at Mitchell Madison Group LLC

President, Chief Executive Officer & Director at Global Blood Therapeutics, Inc.

Senior Vice President, Research at Global Blood Therapeutics, Inc.

Senior Vice President, Clinical Development at Global Blood Therapeutics, Inc.

Chief Accounting Officer at Global Blood Therapeutics, Inc.

Chief Legal Officer at Global Blood Therapeutics, Inc.

Chief Financial Officer at Global Blood Therapeutics, Inc.

Chief Business & Strategy Officer at Global Blood Therapeutics, Inc.

Chief Medical & Chief Operating Officer at Provention Bio, Inc.

Former Chief Scientific Officer at Global Blood Therapeutics, Inc.
See 132 more listings with RelSci Professional.

In The News See More

Marketwired
February 10, 2015

Paths to Peter Radovich

Peter Radovich
You
Connections via Relationship Science
Peter Radovich
Sync your contacts to see how you can connect with Peter Radovich.

Educational Background

 
Texas Christian University (TCU) is a private, coeducational university located in Fort Worth, Texas. The campus is located on 272 acres (1.10 km2) about three miles (8 km) from downtown Fort Worth. TCU is affiliated with, but not governed by, the Disciples of Christ. Its mascot is the "horned frog", and women's teams are known as the Lady Frogs. For most varsity sports TCU competes in the Big 12 conference of the NCAA's Division I. The university enrolls around 9,725 students, with 8,456 being undergraduates. As of October 2011, TCU's total endowment was $1.2 billion.

Career History

Senior Vice President-Operations
2014 - Current
Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.
Vice President-Program Leadership
2004 - 2006
Based in South San Francisco, California, Onyx Pharmaceuticals, Inc. is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer. At Onyx, we are grounded in three leadership hallmarks that guide how we manage our business and build value for patients and shareholders: innovation, patient-centeredness and stewardship.
Professional
Prior
Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA.

Public Holdings

Restricted data only for RelSci Professional users.

Other Affiliations

You've reached your 7 free profiles limit this month.

Upgrade to RelSci Pro today to enjoy unlimited profile views and much more!

Start My Free Trial
Still not convinced? Check out our full listing of features here.